Navigation Links
FDA funds Rochester researchers to give chronic and acute pain clinical trials a makeover
Date:11/14/2011

For chronic pain sufferers, a day can feel like a year and a year can feel like an eternity. With very few truly new therapies approved by the U.S. Food and Drug Administration for this condition since 2005, the outlook is far from bright.

Fortunately, the FDA has taken note. With up to $4.5 million in funding from the agency over the next five years, researchers at the University of Rochester Medical Center will study different approaches to improve the methods used to evaluate and approve new, safe, and effective treatments for the more than 76 million Americans with acute and chronic pain.

"Pain can cause considerable suffering and it represents an enormous financial burden to society," said Robert H. Dworkin, Ph.D., professor in the Department of Anesthesiology and the Center for Human Experimental Therapeutics at the Medical Center, who will spearhead the research. "Despite substantial attention in the pharmaceutical industry to developing novel pain therapies, the fact that so few improved treatments have become available is really surprising and is why the FDA is funding this initiative."

According to Dworkin, one possible reason pain clinical trials are often unsuccessful is that patients in the placebo group, who get a dummy pill instead of the real treatment, frequently show greater-than-expected improvements. Consequently, it becomes difficult for researchers to show meaningful differences between the pain-lessening effects of the real drug and the dummy drug.

The FDA agrees that the problem may lie in the way new pain therapies are identified and studied.

"We've seen over the years that analgesic [pain] clinical trials frequently fail, and often with drugs that we know work. When opioids that have been known to be effective for hundreds of years are put in clinical trials, we can't get a positive result," said Bob Rappaport, director of the Division of Anesthesia, Analgesia, and Addiction Drug Product
'/>"/>

Contact: Emily Boynton
emily_boynton@urmc.rochester.edu
585-273-1757
University of Rochester Medical Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. NIH funds development of new broad-spectrum therapeutics
2. NIH funds continued research in suicide prevention in China
3. Congress must protect funds for aging America, advocates say
4. Society of Interventional Radiology Foundation funds Howard Hughes Medical Institute Award
5. Maryland Stem Cell Research Commission funds 36 new projects in FY 2011
6. Grant funds next phase in bringing healthier sorghum closer to underserved communities
7. NHLBI funds 9 organizations to improve awareness of COPD
8. Philanthropic pledge triples funds for TGen ovarian cancer research
9. NIH funds advanced development of 3 biodefense vaccines
10. European partnership funds research toward robot aides for the elderly
11. The Marilyn B. Gula Mountains of Hope Foundation donates additional research funds to TGen
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... August 20, 2014 Doctors at the University ... wipe out mesothelioma in laboratory mice by injecting them with ... posted details of the study on its website. Click ... with Hong Kong University’s AIDS Institute of Microbiology created a ... or PD-1. By altering DNA, the vaccine is designed to ...
(Date:8/20/2014)... Today, Zane Benefits, the #1 Online ... for 2015. , According to Zane Benefits, with open ... employees are encouraged to start thinking about their healthcare ... open enrollment period will run from November 15, 2014 ... can purchase a new individual health insurance policy, or ...
(Date:8/20/2014)... 20, 2014 The report “Automotive ... - A Global Analysis: by Geography - Trends ... classifies and defines automotive airbag and seatbelt market ... highlights potential growth opportunities in the coming years ... market drivers, restrains, growth indicators, challenges, legislation trends, ...
(Date:8/20/2014)... August 20, 2014 In a recent ... a University College London (UCL) study showed that dental ... method of brushing teeth was the most effective. Analysis ... different tooth-brushing techniques were frequently recommended, but none were ... for Cosmetic Dentistry, experienced cosmetic dentist Dr. ...
(Date:8/20/2014)... Hope For The Warriors® is excited to announce ... in Washington, DC on Thursday, October 2, 2014 at ... the courage of our wounded service members, their families, ... Got Heart, Give Hope® Celebration will benefit Hope For ... sense of self, restoring the family unit, and restoring ...
Breaking Medicine News(10 mins):Health News:New Research Study Finds Vaccine Stops Mesothelioma in Lab Mice, According to Surviving Mesothelioma Website 2Health News:Automotive Airbag Market Worth $23.6 Billion and Automotive Seat Belt Market Worth $9.0 Billion by 2019 – New Report by MarketsandMarkets 2Health News:Automotive Airbag Market Worth $23.6 Billion and Automotive Seat Belt Market Worth $9.0 Billion by 2019 – New Report by MarketsandMarkets 3Health News:Automotive Airbag Market Worth $23.6 Billion and Automotive Seat Belt Market Worth $9.0 Billion by 2019 – New Report by MarketsandMarkets 4Health News:Ending Confusion About the Best Way to Brush Teeth 2Health News:Ending Confusion About the Best Way to Brush Teeth 3Health News:Hope For The Warriors Announces Got Heart, Give Hope Celebration in Washington, DC 2
... May 19 Towards the Electronic,Patient Record ... interface terminology,announced today its next-generation interface terminology ... terminologies access to all of,IMO,s terminology knowledge ... algorithms optimized for millisecond response times in ...
... Sciences (OTC,Bulletin Board: DSCI), a provider of advanced ... Burn Dressing, its flagship wound care,product, was profiled ... Reporter Lisa Thomas-Laury examines the use of ... Leonard Abrams Center for Advanced Wound,Healing of the ...
... Health, Inc., one of,the nation,s largest public/private health ... provider of software agent,technologies for health information exchange, ... clinicians at the point of care., Shared ... the clinical,interface capabilities of what is already one ...
... Should Be ,Wake-Up Call, for Doctors and Women, WASHINGTON, ... coronary artery disease are significantly less likely than,men to be ... WomenHeart - the national coalition for women with heart,disease -- ... sure,that women are getting the care that they need., ...
... May 19 Edifecs, the leader in ... EDS has,selected the Edifecs Healthcare Accelerator Suite ... health care transactions in both,real-time and batch ... of the,EDS MetaVance(R) Administration and Finance System., ...
... of Liverpool has performed a groundbreaking operation on a chimp ... dogs. , The three year-old chimp called Janet was rescued ... in a chimpanzee reserve supported by the Cameroon Wildlife Aid ... because a bone in her forearm - the ulna - ...
Cached Medicine News:Health News:Intelligent Medical Objects (IMO), Inc. announces the General Availability of Its Terminology Portal Service for EMR/EHR and Charge-Capture Applications 2Health News:Intelligent Medical Objects (IMO), Inc. announces the General Availability of Its Terminology Portal Service for EMR/EHR and Charge-Capture Applications 3Health News:Intelligent Medical Objects (IMO), Inc. announces the General Availability of Its Terminology Portal Service for EMR/EHR and Charge-Capture Applications 4Health News:Derma Sciences' MEDIHONEY(TM) Profiled By ABC News' Philadelphia Affiliate 2Health News:Shared Health(R) and Novo Innovations Partner for Improved Information-Sharing of Clinical Health Records 2Health News:Shared Health(R) and Novo Innovations Partner for Improved Information-Sharing of Clinical Health Records 3Health News:Study: Doctors Significantly Less Likely to Provide Women with Treatments to Prevent Heart Attacks 2Health News:EDS Selects Edifecs Healthcare Accelerator Suite for Claims Processing Solution 2Health News:Surgeon operates to rescue chimp with rare deformity 2
(Date:8/20/2014)... Glenmark Pharmaceuticals S.A. (GPSA), ... India (GPL), announces the discovery and initiation of ... candidate, GBR 1302, a HER2xCD3 bispecific antibody. GBR ... Biologics Research Centre located in La Chaux-de-Fonds, ... on Glenmark,s innovative BEAT antibody technology platform which ...
(Date:8/19/2014)... BIRMINGHAM, Ala. , Aug. 19, 2014  The Alabama ... re-affirmed that patients can sue drug makers who mislead doctors ... cause harmful side‑effects.  The case is Weeks v. Wyeth, and ... drug makers in that same case last year. Heninger Garrison ... represent the patient in the case, Danny Weeks ...
(Date:8/19/2014)... -- Minimally Invasive Devices Inc. (MID), a ... that Mitsubishi Corporation has formally agreed to exclusively distribute ... Japan . MID anticipates that FloShield will ... in the second half of 2015. ... Storz GMBH & Co. (endoscopic instruments and devices) in ...
Breaking Medicine Technology:Glenmark Enters Oncology With the Discovery and Initiation of IND Enabling Studies of an Innovative Bispecific Antibody 2Glenmark Enters Oncology With the Discovery and Initiation of IND Enabling Studies of an Innovative Bispecific Antibody 3Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 2Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 3Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 4Minimally Invasive Devices and Mitsubishi Medical Japan Forge Exclusive Distribution Agreement 2
... achieve undetectable viral load in Phase,IIa trial within ... care, SAN FRANCISCO, Nov. 1 New ... protease inhibitor (PI) being,developed by Tibotec BVBA for ... Tibotec will present findings from three TMC435 studies,including ...
... Higher Sustained Virological Response Rates Recognized as Marker ... 1 A new,independently-conducted study being presented at ... the Study of Liver Diseases (AASLD) shows that,PEGASYS(R) ... response (SVR) rates for hepatitis C patients as,compared ...
Cached Medicine Technology:Tibotec Presents Interim Findings for TMC435, an Investigational Genotype 1 Hepatitis C Treatment, at the AASLD Liver Meeting 2008 2Tibotec Presents Interim Findings for TMC435, an Investigational Genotype 1 Hepatitis C Treatment, at the AASLD Liver Meeting 2008 3Tibotec Presents Interim Findings for TMC435, an Investigational Genotype 1 Hepatitis C Treatment, at the AASLD Liver Meeting 2008 4Tibotec Presents Interim Findings for TMC435, an Investigational Genotype 1 Hepatitis C Treatment, at the AASLD Liver Meeting 2008 5New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients 2New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients 3New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients 4New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients 5New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients 6New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients 7
... and model 1488 active-fixation leads are among ... the unsurpassed handling advantages, performance, and reliability ... active-fixation leads. Implantable with a 7 F ... Tendril SDX lead is designed to lower ...
... CheckPoint is an automated, wireless, computerized ... alert system for refrigerator, freezer, incubator ... recorders, data loggers and manual temperature ... an existing PC and comes complete ...
... This requiring no water for ... hand hygiene to physically clean ... is either not an option ... allows you to return to ...
BioSoft alcohol gel hand antiseptic with soothing moisturizers is a fast-acting, broad-spectrum antimicrobial solution. BioSoft alcohol gel hand antiseptic applies easily, requires no rinsing and dri...
Medicine Products: